Ruiu Stefania, Marchese Giorgio, Saba Pier Luigi, Satta Rosalba, Gessa GianLuigi, Vaccari Andrea, Pani Luca
Neuroscienze S.c.a.r.l., Via Palabanda 9, Cagliari 09123, Italy.
Br J Pharmacol. 2003 Jan;138(1):188-92. doi: 10.1038/sj.bjp.0705009.
1 The neuroleptic [(3)H]-haloperidol (HP) was taken up in synaptosomes prepared from rat brain, in a temperature-, sodium ion-, and energy-dependent process. 2 The highest concentration of uptake sites (V(max)=2.37 pmol mg(-1) protein min(-1)) was in the striatum with the other brain areas displaying lower (by 50-70%) values. 3 The affinity values (K(m) approximately equal to 40 nM) were similar in all brain areas considered. 4 The pharmacological characterization did not indicate a well-defined group of inhibitors, which suggested that HP might not use a transporter for recognized neurotransmitters. 5 The HP metabolites tested, including HPTP, were competitive inhibitors of [(3)H]-HP uptake, an indirect indication that they may actively enter the striatal nerve endings through the same carrier. 6 Since the uptake process was partially affected by the incubation of [(3)H]-HP in the presence of several antagonists of HP-transforming cytochrome P450 isoforms, the binding of HP at some enzyme sites inside the synaptosome cannot be excluded. 7 In conclusion, the present results suggest that HP may be actively transported in the rat brain.
抗精神病药物[(3)H] - 氟哌啶醇(HP)以温度、钠离子和能量依赖的方式被摄取到从大鼠脑制备的突触体中。
摄取位点的最高浓度(V(max)=2.37 pmol mg(-1)蛋白质min(-1))在纹状体中,其他脑区的值较低(低50 - 70%)。
在所有考虑的脑区中,亲和值(K(m)约等于40 nM)相似。
药理学特征未表明存在明确的抑制剂组,这表明HP可能不通过公认神经递质的转运体进行转运。
所测试的HP代谢产物,包括HPTP,是[(3)H] - HP摄取的竞争性抑制剂,这间接表明它们可能通过同一载体主动进入纹状体神经末梢。
由于在几种HP转化细胞色素P450同工型拮抗剂存在下[(3)H] - HP的孵育对摄取过程有部分影响,不能排除HP在突触体内某些酶位点的结合。
总之,目前的结果表明HP可能在大鼠脑中被主动转运。